Wu, Xing <br/><br/>
Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.  [electronic resource] 

 -  Journal of neuro-oncology  Apr 2016 
 - 221-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7373 
<br/><br/><label>Standard No.: </label>10.1007/s11060-015-2039-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen--genetics<br/>Adolescent<br/>Adult<br/>Aged<br/>Biomarkers, Tumor--genetics<br/>Brain Neoplasms--genetics<br/>Child<br/>Child, Preschool<br/>DNA Methylation<br/>Female<br/>Follow-Up Studies<br/>Glioma--genetics<br/>Humans<br/>Immunoenzyme Techniques<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplastic Stem Cells--metabolism<br/>Prognosis<br/>Promoter Regions, Genetic--genetics<br/>Survival Rate<br/>Young Adult